Sign in
4

Changes in Ownership

Acumen Pharmaceuticals, Inc. Filed Acc 0001209191-23-003735

Chief Legal Office & Corp Sec acquired 26,800 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Meisner Derek M Chief Legal Office & Corp Sec 2023-01-17 Grant or award +26,800 26,800 D
Derivatives
Meisner Derek M Chief Legal Office & Corp Sec 2023-01-17 Grant or award · Employee Stock Option (right to buy) +120,800 120,800 D
Loading xslF345X03/doc4.xml…